SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-18-247326
Filing Date
2018-08-13
Accepted
2018-08-13 16:33:01
Documents
49
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d570114d10q.htm 10-Q 364309
2 EX-10.2 d570114dex102.htm EX-10.2 303236
3 EX-31.1 d570114dex311.htm EX-31.1 6200
4 EX-31.2 d570114dex312.htm EX-31.2 6183
5 EX-32.1 d570114dex321.htm EX-32.1 3410
6 EX-32.2 d570114dex322.htm EX-32.2 3383
  Complete submission text file 0001193125-18-247326.txt   3103171

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ogen-20180630.xml EX-101.INS 400466
8 XBRL TAXONOMY EXTENSION SCHEMA ogen-20180630.xsd EX-101.SCH 41223
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ogen-20180630_cal.xml EX-101.CAL 31821
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ogen-20180630_def.xml EX-101.DEF 152394
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ogen-20180630_lab.xml EX-101.LAB 327024
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ogen-20180630_pre.xml EX-101.PRE 225885
Mailing Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634
Business Address 4902 EISENHOWER BLVD SUITE 125 TAMPA FL 33634 8132867900
ORAGENICS INC (Filer) CIK: 0001174940 (see all company filings)

IRS No.: 593410522 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32188 | Film No.: 181012657
SIC: 2834 Pharmaceutical Preparations